The experimental group was characterized by suboptimal metabolic control of 7.1 ± 1%, with a mean diabetes duration of 11.8 ± 6.2 years and an average duration of treatment with a personal insulin pump of 6.9 ± 4.2 years (Table 2). This evidence concerns the gene INS and diabetes mellitus.